SK159597A3 - Use of alendronate for the prevention of osteoporosis - Google Patents
Use of alendronate for the prevention of osteoporosis Download PDFInfo
- Publication number
- SK159597A3 SK159597A3 SK1595-97A SK159597A SK159597A3 SK 159597 A3 SK159597 A3 SK 159597A3 SK 159597 A SK159597 A SK 159597A SK 159597 A3 SK159597 A3 SK 159597A3
- Authority
- SK
- Slovakia
- Prior art keywords
- alendronate
- osteoporosis
- years
- placebo
- aln
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45819595A | 1995-06-02 | 1995-06-02 | |
| PCT/US1996/007912 WO1996038156A1 (en) | 1995-06-02 | 1996-05-29 | Use of alendronate for the prevention of osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK159597A3 true SK159597A3 (en) | 1998-06-03 |
Family
ID=23819759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1595-97A SK159597A3 (en) | 1995-06-02 | 1996-05-29 | Use of alendronate for the prevention of osteoporosis |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0828496A1 (de) |
| JP (1) | JPH10506648A (de) |
| KR (1) | KR19990022436A (de) |
| CN (1) | CN1192685A (de) |
| AU (1) | AU709196B2 (de) |
| BG (1) | BG63103B1 (de) |
| BR (1) | BR9609020A (de) |
| CA (1) | CA2222318A1 (de) |
| CZ (1) | CZ381197A3 (de) |
| EA (1) | EA000677B1 (de) |
| EE (1) | EE03306B1 (de) |
| HU (1) | HUP9900659A3 (de) |
| IL (1) | IL118422A0 (de) |
| IS (1) | IS4617A (de) |
| NO (1) | NO975527L (de) |
| NZ (1) | NZ308935A (de) |
| PL (1) | PL323669A1 (de) |
| SK (1) | SK159597A3 (de) |
| TR (1) | TR199701482T1 (de) |
| WO (1) | WO1996038156A1 (de) |
| ZA (1) | ZA964465B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
| SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
| KR100317935B1 (ko) * | 1999-10-20 | 2001-12-22 | 유승필 | 대사성 골질환 치료용 약제조성물 및 이의 제조방법 |
| ES2268086T3 (es) * | 2001-05-02 | 2007-03-16 | Novartis Ag | Metodo de administracion de bisfosfonatos por inhalacion en el tratamiento o prevencion de la resorcion osea y la osteoporosis. |
| JP2010043119A (ja) * | 2009-10-16 | 2010-02-25 | Gador Sa | 骨の代謝病の予防および／または治療のための組成物、その組成物の調製方法およびその使用 |
| KR102472749B1 (ko) * | 2022-01-18 | 2022-12-02 | 주식회사 위엔씨 | 유해가스제거 및 항균탈취기능을 함유한 흡착소재 제조방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366965A (en) * | 1993-01-29 | 1994-11-22 | Boehringer Mannheim Gmbh | Regimen for treatment or prophylaxis of osteoporosis |
| US5462932A (en) * | 1994-05-17 | 1995-10-31 | Merck & Co., Inc. | Oral liquid alendronate formulations |
-
1996
- 1996-05-27 IL IL11842296A patent/IL118422A0/xx unknown
- 1996-05-29 PL PL96323669A patent/PL323669A1/xx unknown
- 1996-05-29 CA CA002222318A patent/CA2222318A1/en not_active Abandoned
- 1996-05-29 HU HU9900659A patent/HUP9900659A3/hu unknown
- 1996-05-29 SK SK1595-97A patent/SK159597A3/sk unknown
- 1996-05-29 NZ NZ308935A patent/NZ308935A/en unknown
- 1996-05-29 EP EP96920553A patent/EP0828496A1/de not_active Withdrawn
- 1996-05-29 WO PCT/US1996/007912 patent/WO1996038156A1/en not_active Application Discontinuation
- 1996-05-29 TR TR97/01482T patent/TR199701482T1/xx unknown
- 1996-05-29 EE EE9700308A patent/EE03306B1/xx not_active IP Right Cessation
- 1996-05-29 EA EA199700449A patent/EA000677B1/ru not_active IP Right Cessation
- 1996-05-29 CZ CZ973811A patent/CZ381197A3/cs unknown
- 1996-05-29 BR BR9609020A patent/BR9609020A/pt not_active Application Discontinuation
- 1996-05-29 CN CN96196075A patent/CN1192685A/zh active Pending
- 1996-05-29 KR KR1019970708917A patent/KR19990022436A/ko not_active Application Discontinuation
- 1996-05-29 JP JP8536616A patent/JPH10506648A/ja active Pending
- 1996-05-29 AU AU58824/96A patent/AU709196B2/en not_active Ceased
- 1996-05-31 ZA ZA964465A patent/ZA964465B/xx unknown
-
1997
- 1997-11-19 IS IS4617A patent/IS4617A/is unknown
- 1997-11-20 BG BG102060A patent/BG63103B1/bg unknown
- 1997-12-01 NO NO975527A patent/NO975527L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TR199701482T1 (xx) | 1998-03-21 |
| IS4617A (is) | 1997-11-19 |
| CZ381197A3 (cs) | 1998-06-17 |
| CN1192685A (zh) | 1998-09-09 |
| CA2222318A1 (en) | 1996-12-05 |
| EP0828496A1 (de) | 1998-03-18 |
| KR19990022436A (ko) | 1999-03-25 |
| JPH10506648A (ja) | 1998-06-30 |
| EE03306B1 (et) | 2000-12-15 |
| BR9609020A (pt) | 1999-07-06 |
| HUP9900659A2 (hu) | 2001-04-28 |
| NO975527D0 (no) | 1997-12-01 |
| EA000677B1 (ru) | 2000-02-28 |
| AU709196B2 (en) | 1999-08-26 |
| AU5882496A (en) | 1996-12-18 |
| IL118422A0 (en) | 1996-09-12 |
| BG63103B1 (bg) | 2001-04-30 |
| PL323669A1 (en) | 1998-04-14 |
| NO975527L (no) | 1997-12-01 |
| WO1996038156A1 (en) | 1996-12-05 |
| ZA964465B (en) | 1996-12-11 |
| HUP9900659A3 (en) | 2002-12-28 |
| EA199700449A1 (ru) | 1998-06-25 |
| NZ308935A (en) | 2000-07-28 |
| BG102060A (en) | 1998-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5616571A (en) | Bisphosphonates prevent bone loss associated with immunosuppressive therapy | |
| KR19980702210A (ko) | 비척추골 골절의 위험률을 감소시키는 방법 | |
| EP1714648A1 (de) | Kombinationsarzneimittel | |
| AU703887B2 (en) | Bisphosphonate therapy for bone loss associated with rheumatoid arthritis | |
| SK159597A3 (en) | Use of alendronate for the prevention of osteoporosis | |
| US20020169148A1 (en) | Use of alendronate for the prevention of osteoporosis | |
| KR19980702209A (ko) | 척추 골절의 위험을 경감시키는 방법 | |
| US5914099A (en) | Prevention of tooth loss by the administration of alendronate or its salts | |
| JP2001508769A (ja) | アレンドロン酸塩及び胃排出を促進する薬剤を含有する医薬組成物 | |
| Standard | Pr TEVA-RISEDRONATE | |
| KR20090037347A (ko) | ＨＭＧ－ＣｏＡ 환원효소억제제와 담즙산을 포함하는 Ｃ형 간염 치료용 약학조성물 | |
| MXPA97009906A (en) | Use of bisphosphonates to prepare compositions to prevent loss of associated bone conterapia immunosupres | |
| MXPA97009426A (en) | Use of alendronate to prepare compositions for the prevention of osteoporo | |
| MXPA97006277A (en) | The use of alendronate to prepare compositions to reduce the risk of non-vertebrate bit fractures |